Sun Pharma (Netherlands) B.V. 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-09 4:05 pm Unchanged |
2021-03-01 | 13G | Krystal Biotech, Inc. KRYS |
Sun Pharma (Netherlands) B.V. | 914,107 4.100% |
0 (Unchanged) |
Filing |